Goldman Removes Apple $AAPL from Conviction List, Raises PT to $232, Adds Amgen, Monday, Vulcan Materials, Removes Merck, Vertex
Goldman Sachs has removed Apple $AAPL from its Conviction List, causing Apple's stock to slide. Despite the removal, Goldman maintains a buy rating on Apple, with a price target raised to $232 from $223. The Conviction List changes also include additions of Amgen $AMGN, Monday $MNDY, and Vulcan Materials $VMC, while removing Merck $MRK and Vertex Pharmaceuticals $VRTX. The market reacts to the news with Apple shares dipping 0.4% after the removal from the Conviction List.
Sources
Special Situations 🌐 Research Newsletter (Jay)
Apple $AAPL is no longer on GS conviction buy list for the first time in years
*Walter Bloomberg $AAPL APPLE SHARES DIP 0.4% AFTER GOLDMAN SACHS REMOVES STOCK FROM ITS CONVICTION LIST
Mukund Mohan $AAPL Goldman Sachs removes Apple from the conviction buy list and adds Amgen to the conviction buy list Goldman removed the tech giant from its conviction buy list, but said it was sticking with its long-term buy rating on the stock. The firm also added Amgen to its conviction…
